FibroBiologics is pursuing a development program for CYPS317 with the goal of advancing first-in-human clinical trials following FDA review of the IND filing. The IND submission includes comprehensive ...
The Ministry of Corporate Affairs (MCA) on Tuesday extended the deadline for filing financial statements and annual returns ...
The corporate affairs ministry on Tuesday extended the deadline for filing of financial statements and annual returns under ...
The MCA has allowed companies to file annual returns and financial statements for FY 2024–25 up to 31 January 2026 without additional fees. The key takeaway is a temporary but significant compliance ...